Literature DB >> 33686968

A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.

Kai Wang1,2, Chenan Guan1,3, Xianwen Shang1,2, Xiang Ying1,2, Shuangshuang Mei1,2, Hanxiao Zhu1,2, Liang Xia4, Zeying Chai1,2.   

Abstract

Fc fragment of IgG-binding protein (FCGBP) is differentially expressed in various tumors. However, the correlation between FCGBP and immune cell infiltration in ovarian cancer remains unclear. FCGBP expression was analyzed using The Cancer Genome Atlas (TCGA) pan-cancer data, and the ovarian cancer expression profile was analyzed using the Gene Expression Omnibus database. The clinical prognostic value of FCGBP was evaluated using clinical survival data from TCGA. Enrichment analysis of FCGBP was performed using the R package clusterProfiler. Based on known immune cell infiltration scores for samples found in TCGA, we analyzed the association between immune cell infiltration level and FCGBP expression. FCGBP was highly expressed and associated with poorer overall survival (p = 0.00051) and disease-specific survival (p = 0.0012) in ovarian cancer and other tumors. Additionally, high FCGBP expression correlated significantly with immune-related gene sets, including those involved in chemokine signaling pathways and innate and adaptive immunity. Further analysis showed that M2 macrophage infiltration increased and M1 macrophage infiltration decreased in tissues with high FCGBP expression. Our study suggests that FCGBP contributes to M2 macrophage polarization by acting as an oncogene in ovarian cancer. FCGBP may represent a clinically helpful biomarker for predicting overall survival of ovarian cancer patients.

Entities:  

Keywords:  Fc fragment of IgG binding protein; biomarker; ovarian cancer

Year:  2021        PMID: 33686968      PMCID: PMC7993703          DOI: 10.18632/aging.202601

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  23 in total

Review 1.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences.

Authors:  Florian R Greten; Sergei I Grivennikov
Journal:  Immunity       Date:  2019-07-16       Impact factor: 31.745

2.  The Immune Landscape of Cancer.

Authors:  Vésteinn Thorsson; David L Gibbs; Scott D Brown; Denise Wolf; Dante S Bortone; Tai-Hsien Ou Yang; Eduard Porta-Pardo; Galen F Gao; Christopher L Plaisier; James A Eddy; Elad Ziv; Aedin C Culhane; Evan O Paull; I K Ashok Sivakumar; Andrew J Gentles; Raunaq Malhotra; Farshad Farshidfar; Antonio Colaprico; Joel S Parker; Lisle E Mose; Nam Sy Vo; Jianfang Liu; Yuexin Liu; Janet Rader; Varsha Dhankani; Sheila M Reynolds; Reanne Bowlby; Andrea Califano; Andrew D Cherniack; Dimitris Anastassiou; Davide Bedognetti; Younes Mokrab; Aaron M Newman; Arvind Rao; Ken Chen; Alexander Krasnitz; Hai Hu; Tathiane M Malta; Houtan Noushmehr; Chandra Sekhar Pedamallu; Susan Bullman; Akinyemi I Ojesina; Andrew Lamb; Wanding Zhou; Hui Shen; Toni K Choueiri; John N Weinstein; Justin Guinney; Joel Saltz; Robert A Holt; Charles S Rabkin; Alexander J Lazar; Jonathan S Serody; Elizabeth G Demicco; Mary L Disis; Benjamin G Vincent; Ilya Shmulevich
Journal:  Immunity       Date:  2018-04-05       Impact factor: 43.474

3.  NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer.

Authors:  Li Xiong; Yu Wen; Xiongying Miao; Zhulin Yang
Journal:  Cell Tissue Res       Date:  2013-12-06       Impact factor: 5.249

4.  Robust enumeration of cell subsets from tissue expression profiles.

Authors:  Aaron M Newman; Chih Long Liu; Michael R Green; Andrew J Gentles; Weiguo Feng; Yue Xu; Chuong D Hoang; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Methods       Date:  2015-03-30       Impact factor: 28.547

5.  Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages.

Authors:  Xiang Ying; Quanfeng Wu; Xiaoli Wu; Qinyi Zhu; Xinjing Wang; Lu Jiang; Xin Chen; Xipeng Wang
Journal:  Oncotarget       Date:  2016-07-12

Review 6.  Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 7.  Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches.

Authors:  Innocenza Palaia; Federica Tomao; Carolina Maria Sassu; Lucia Musacchio; Pierluigi Benedetti Panici
Journal:  Onco Targets Ther       Date:  2020-06-26       Impact factor: 4.147

8.  CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway.

Authors:  Yihan Bai; Kemin Yin; Tong Su; Fang Ji; Shu Zhang
Journal:  Onco Targets Ther       Date:  2020-06-17       Impact factor: 4.147

9.  FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients.

Authors:  Yating Wang; Yan Liu; Huiqiao Liu; Qingan Zhang; Hongyan Song; Jianliang Tang; Jiangtao Fu; Xiaofei Wang
Journal:  Oncotarget       Date:  2017-09-23

10.  The Tumor Suppressor TFF1 Occurs in Different Forms and Interacts with Multiple Partners in the Human Gastric Mucus Barrier: Indications for Diverse Protective Functions.

Authors:  Jörn Heuer; Franziska Heuer; René Stürmer; Sönke Harder; Hartmut Schlüter; Nayara Braga Emidio; Markus Muttenthaler; Dörthe Jechorek; Frank Meyer; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

View more
  6 in total

1.  Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer.

Authors:  Xiaoguang Wang; Man Ni; Daxiong Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-08       Impact factor: 2.650

2.  FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.

Authors:  Ting Shen; Jianying Zhang; Yali Wang; Binjie Liu
Journal:  J Immunol Res       Date:  2022-06-12       Impact factor: 4.493

Review 3.  Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer.

Authors:  Qiao Liu; Xia Niu; Yang Li; Jia-Rui Zhang; Shao-Jun Zhu; Qi-Yuan Yang; Wei Zhang; Li Gong
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

4.  Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review.

Authors:  Sara Andrade; Tiago Morais; Ionel Sandovici; Alexandre L Seabra; Miguel Constância; Mariana P Monteiro
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-29       Impact factor: 5.555

5.  FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.

Authors:  Tengfeng Yan; Daofeng Tian; Junhui Chen; Yinqiu Tan; Yue Cheng; Liguo Ye; Gang Deng; Baohui Liu; Fanen Yuan; Shenqi Zhang; Linzhi Cai; Qianxue Chen
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

6.  Spatial maps of hepatocellular carcinoma transcriptomes highlight an unexplored landscape of heterogeneity and a novel gene signature for survival.

Authors:  Nan Zhao; Yanhui Zhang; Runfen Cheng; Danfang Zhang; Fan Li; Yuhong Guo; Zhiqiang Qiu; Xueyi Dong; Xinchao Ban; Baocun Sun; Xiulan Zhao
Journal:  Cancer Cell Int       Date:  2022-02-02       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.